Molecular modeling of the interaction of ligands with ACE2–SARS-CoV-2 spike protein complex
- 7 October 2021
- journal article
- website
- Published by Springer Science and Business Media LLC in In Silico Pharmacology
Abstract
In Silico Pharmacology provides a forum for research articles at the cross-roads of computation, pharmacology, toxicology and pharmaceutics, and is relevant ...Keywords
This publication has 115 references indexed in Scilit:
- Angiotensin Receptor Blockers: Pharmacology, Efficacy, and SafetyThe Journal of Clinical Hypertension, 2011
- Angiotensin-Converting Enzyme InhibitorsThe Journal of Clinical Hypertension, 2011
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2Journal of Virology, 2010
- The ACE and I: how ACE inhibitors came to beThe FASEB Journal, 2006
- Structure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 InhibitorHypertension, 2004
- UCSF Chimera?A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II ReceptorsHypertension, 2004
- ACE Inhibition with MoexiprilAmerican Journal of Cardiovascular Drugs, 2003
- FosinoprilDrugs, 1992
- Pharmacokinetics, Safety, and Pharmacologic Effects of Fosinopril Sodium, an Angiotensin‐Converting Enzyme Inhibitor in Healthy SubjectsThe Journal of Clinical Pharmacology, 1991